Medical Tests
Explore lab tests, blood work, and imaging exams with plain-language preparation and overview pages.
Browse Directory Sections
All medical tests (102,751)
Other
ALPRAZolam [Presence] in Gastric fluid
Other
ALPRAZolam [Presence] in Saliva (oral fluid)
Blood test
ALPRAZolam [Presence] in Serum or Plasma
Other
ALPRAZolam [Presence] in Specimen
Other
ALPRAZolam [Presence] in Urine
Other
ALPRAZolam [Presence] in Urine by Confirmatory method
Other
ALPRAZolam [Presence] in Urine by Screen method
Other
ALPRAZolam cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
Other
ALPRAZolam cutoff [Mass/volume] in Urine for Confirmatory method
Blood test
ALPRAZolam induced platelet IgG Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Blood test
ALPRAZolam induced platelet IgM Ab [Presence] in Serum or Plasma by Flow cytometry (FC)
Other
ALPRAZolam/Creatinine [Mass Ratio] in Urine by Confirmatory method
Blood test
ALS2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Blood test
ALS4 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Blood test
AM-2201 (synthetic cannabinoid) [Presence] in Blood
Other
AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) [Mass/volume] in Urine by Confirmatory method
Blood test
AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Blood
Other
AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
Other
AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite) cutoff [Mass/volume] in Urine for Confirmatory method
Other
AM-2201 4-hydroxypentyl (synthetic cannabinoid metabolite)/Creatinine [Mass Ratio] in Urine
Other
AM694 N-5-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
Blood test
AML/MDS gene 7q31 deletion [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Blood test
AML/MDS gene CEP 8 trisomy [Presence] in Blood or Tissue by Molecular genetics method
Blood test
AMPAR1 Ab [Measurement] in Serum
Other
AMPAR1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
Blood test
AMPAR1 Ab [Presence] in Serum by Cell binding immunofluorescent assay
Blood test
AMPAR1 Ab [Presence] in Serum by Immunofluorescence
Other
AMPAR1 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay
Blood test
AMPAR1 Ab [Titer] in Serum by Cell binding immunofluorescent assay
Other
AMPAR1 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Blood test
AMPAR1 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence
Other
AMPAR1+AMPAR2 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Blood test
AMPAR1+AMPAR2 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence
Blood test
AMPAR1+AMPAR2 IgG Ab [Titer] in Serum by Cell binding immunofluorescent assay
Blood test
AMPAR2 Ab [Measurement] in Serum
Other
AMPAR2 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
Blood test
AMPAR2 Ab [Presence] in Serum by Cell binding immunofluorescent assay
Blood test
AMPAR2 Ab [Presence] in Serum by Immunofluorescence
Other
AMPAR2 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay
Blood test
AMPAR2 Ab [Titer] in Serum by Cell binding immunofluorescent assay
Other
AMPAR2 IgG Ab [Measurement] in Cerebral spinal fluid
Blood test
AMPAR2 IgG Ab [Measurement] in Serum or Plasma
Other
AMPAR2 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
Other
AMPAR2 IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
Blood test
AMPAR2 IgG Ab [Presence] in Serum or Plasma by Cell binding immunofluorescent assay
Blood test
AMPAR2 IgG Ab [Presence] in Serum or Plasma by Immunofluorescence
Other
AMPAR2 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
Blood test
AMPAR2 IgG Ab [Titer] in Serum or Plasma by Immunofluorescence
Blood test
AMPD1 gene p.Gln12Ter and p.Pro48Leu [Presence] in Blood or Tissue by Molecular genetics method
Blood test
ANG gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Blood test
ANKK1 gene c.2137G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal
Other
AO modifiers
Other
AO neurologic injury
Other
AP postural sway score [NIH Toolbox] --eyes closed and on foam surface
Other
AP postural sway score [NIH Toolbox] --eyes closed and on solid surface
Other
AP postural sway score [NIH Toolbox] --eyes open and in tandem stance and on solid surface
Other
AP postural sway score [NIH Toolbox] --eyes open and on foam surface
Other
AP postural sway score [NIH Toolbox] --eyes open and on solid surface
Other
AP-3 complex Ab [Titer] in Specimen
Other
AP-3 complex IgG Ab [Presence] in Specimen
Blood test
APC gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
Blood test
APC gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
Blood test
APC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Blood test
APC gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
Blood test
APC gene p.Ile1307Lys [Presence] in Blood or Tissue by Molecular genetics method
Blood test
APOA1 gene full mutation analysis in Blood or Tissue by Sequencing
Blood test
APOA2 gene full mutation analysis in Blood or Tissue by Sequencing
Blood test
APOB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Blood test
APOB gene p.Arg3500Gln and p.Arg3500Trp [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Blood test
APOB gene+LDLR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Blood test
APOB+LDLR+PCSK9 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Blood test
APOE gene allele 1 [Identifier] in Blood or Tissue by Molecular genetics method
Blood test
APOE gene allele 2 [Identifier] in Blood or Tissue by Molecular genetics method
Blood test
APOE gene alleles e2 and e3 and e4 [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Blood test
APOE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Blood test
APOL1 [Genotype] in Blood, Tissue or Saliva by Molecular genetics method Nominal
Other
APOL1 inferred genotype [Identifier] in Plasma from Donor
Blood test
APP gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Other
APTA Registry identifiers panel
Other
APTA Registry organization data panel
Other
APTA Registry patient episode of care panel
Other
APTA Registry patient registration panel
Other
APTA Registry provider data panel
Blood test
APTX gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Blood test
APTX gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Blood test
AR gene CAG repeats [Presence] in Blood or Tissue by Molecular genetics method
Blood test
AR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Blood test
AR gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Other
ARIPiprazole [Mass/mass] in Hair
Blood test
ARIPiprazole [Mass/volume] in Blood
Other
ARIPiprazole [Mass/volume] in Body fluid
Blood test
ARIPiprazole [Mass/volume] in Serum or Plasma
Blood test
ARIPiprazole [Mass/volume] in Serum or Plasma --trough
Other
ARIPiprazole [Mass/volume] in Urine by Confirmatory method
Blood test
ARIPiprazole [Measurement] in Serum or Plasma
Blood test
ARIPiprazole [Moles/volume] in Serum or Plasma
Blood test
ARIPiprazole [Presence] in Serum or Plasma by Screen method
Other
ARIPiprazole [Presence] in Urine by Screen method
Other
ARIPiprazole cutoff [Mass/volume] in Urine for Confirmatory method
Other
ARIPiprazole/Creatinine [Mass Ratio] in Urine by Confirmatory method